Verastem Inc is a biopharmaceutical company engaged in discovering and developing drugs to improve outcomes for patients with cancer. Its product candidates include duvelisib and defactinib.
| Website: | www.verastem.com |
| Email: | bsullivan@verastem.com |
| Main Phone: | +1 781 292-4200 |
| Address: | 117 Kendrick Street |
| Address 2: | Suite 500 |
| State: | MA |
| City / Town: | Needham |
| Country: | USA |
| Postal Code: | 02494 |
| Exchange: | NSD |
| CEO: | Robert Forrester |
| Employees: | 69 |
| NAICS: | Pharmaceutical Preparation Manufacturing (325412) |
| Last Price 8.31 | Change $ 0.18 | Change % 2.21 | Tick N/A |
| Bid 8.30 | Bid Size 600.00 | Ask 8.38 | Ask Size 100.00 |
| Open 8.08 | High 8.57 | Low 7.96 | Prev Close 8.13 |
| Last Trade | Volume 2.2 mi | 52 Wk Hi 9.07 | 52 Wk Low 2.77 |
| Market Cap 550.6 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 66,251,827.00 | EPS (TTM) -1.81 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 2 | 3 |
| Number of Buys | 2 | 3 |
| Number of Sells | 0 | 0 |
| Net Activity | 10700 | 71238 |
| Last 10 Buys | Shares |
|---|---|
| Steven H. Bloom | 1,000 |
| Joseph M. Lobacki | 1,000 |
| Timothy J. Barberich | 1,000 |
| Timothy J. Barberich | 1,000 |
| Monica Kleinman | 1,000 |
| John B. Green | 1,000 |
| Robert Forrester | 1,000 |
| John B. Green | 1,000 |
| Daniel Paterson | 1,000 |
| Robert Forrester | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| N/A | 0 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 17 | 17 | 17 | 17 |
| Low Target Price Estimate | 7 | 7 | 7 | 7 |
| Mean Target Price Estimate | 13.14 | 13.14 | 13.14 | 13.14 |
| Standard Deviation | 3.72 | 3.72 | 3.72 | 3.72 |
| Date of Most Recent Estimate | 05/31/18 | 05/22/18 | 05/22/18 | 05/31/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 424B5 | Prospectus filed under Rule 424(b)(5) | 39 | 2018-06-14 |
| S-3MEF | Registration of up to an additional 20% of securities for any offering registered on a S-3 | 7 | 2018-06-14 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-12 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-12 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 5 |
| Moderate Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.14 | 1.14 | 1.17 | 1.17 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
